What is Acumen Pharmaceuticals, Inc. Common Stock's Market Cap?

Acumen Pharmaceuticals, Inc. Common Stock's Market Cap is $228.5M, based on as-reported figures from SEC (XBRL) filings.

What is Acumen Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Acumen Pharmaceuticals, Inc. Common Stock's Enterprise Value is $130.2M, based on as-reported figures from SEC (XBRL) filings.

What is Acumen Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Acumen Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Acumen Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Acumen Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$105.0M, based on as-reported figures from SEC (XBRL) filings.

What is Acumen Pharmaceuticals, Inc. Common Stock's EBITDA?

Acumen Pharmaceuticals, Inc. Common Stock's EBITDA is -$105.4M, based on as-reported figures from SEC (XBRL) filings.

What is Acumen Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Acumen Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.

What is Acumen Pharmaceuticals, Inc. Common Stock's Net Debt?

Acumen Pharmaceuticals, Inc. Common Stock's Net Debt is -$98.3M, based on as-reported figures from SEC (XBRL) filings.

Acumen Pharmaceuticals, Inc. Common Stock (ABOS) Financial Statements

Acumen Pharmaceuticals, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG0058YJ326

XNAS · usd

3.16▼ 0.02 (-0.63%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.18

Day's Range3.08 – 3.29

52-Week Range1.21 – 3.60

Volume357.7K

Avg Volume363.4K

Share Statistics

Shares Outstanding

Employees61

ExchangeXNAS

Listed2021-07-01

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Acumen Pharmaceuticals, Inc. Common Stock (ABOS)

What is Acumen Pharmaceuticals, Inc. Common Stock's Market Cap?: Acumen Pharmaceuticals, Inc. Common Stock's Market Cap is $228.5M, based on as-reported figures from SEC (XBRL) filings.
What is Acumen Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Acumen Pharmaceuticals, Inc. Common Stock's Enterprise Value is $130.2M, based on as-reported figures from SEC (XBRL) filings.
What is Acumen Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Acumen Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Acumen Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Acumen Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$105.0M, based on as-reported figures from SEC (XBRL) filings.
What is Acumen Pharmaceuticals, Inc. Common Stock's EBITDA?: Acumen Pharmaceuticals, Inc. Common Stock's EBITDA is -$105.4M, based on as-reported figures from SEC (XBRL) filings.
What is Acumen Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Acumen Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.
What is Acumen Pharmaceuticals, Inc. Common Stock's Net Debt?: Acumen Pharmaceuticals, Inc. Common Stock's Net Debt is -$98.3M, based on as-reported figures from SEC (XBRL) filings.